LUNG ADENOSQUAMOUS CARCINOMA

Clinical trials for LUNG ADENOSQUAMOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LUNG ADENOSQUAMOUS CARCINOMA trials appear

Sign up with your email to follow new studies for LUNG ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Radiation boost for tough lung cancers: can it extend lives?

Disease control Terminated

This study is for people with advanced non-small cell lung cancer that has low levels of a marker called PD-L1. It compares the standard immunotherapy treatment (with or without chemo) to the same treatment plus a short course of radiation. The goal is to see if adding radiation …

Matched conditions: LUNG ADENOSQUAMOUS CARCINOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

LUNG ADENOSQUAMOUS CARCINOMA

Get alerted when new LUNG ADENOSQUAMOUS CARCINOMA trials appear

Radiation boost for tough lung cancers: can it extend lives?